ロード中...
Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN): Phase 3 Randomized Controlled Clinical Trial
BACKGROUND AND OBJECTIVES: Diabetic kidney disease is an important complication of type 2 diabetes. In a phase 2b study, adding esaxerenone to renin-angiotensin system inhibitors dose dependently reduced the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and microalbuminuria. T...
保存先:
| 出版年: | Clin J Am Soc Nephrol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Nephrology
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7769030/ https://ncbi.nlm.nih.gov/pubmed/33239409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.06870520 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|